Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term
10:40am, Tuesday, 06'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
06:00am, Friday, 02'nd Jan 2026
BOSTON, Jan. 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francis
Earn Twice The Yield You Get From Bank On HAE Stock
12:50pm, Tuesday, 30'th Dec 2025
Currently priced at approximately $80.53 per share, Haemonetics (NYSE: HAE) is trading roughly 7.6% below its 52-week high.
Haemonetics (NYSE:HAE) and Trident Brands (OTCMKTS:TDNT) Critical Contrast
03:17am, Thursday, 25'th Dec 2025
Trident Brands (OTCMKTS:TDNT - Get Free Report) and Haemonetics (NYSE: HAE - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on t
Here's Why Haemonetics (HAE) is a Strong Growth Stock
10:46am, Friday, 19'th Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Haemonetics (HAE) is a Strong Momentum Stock
10:51am, Monday, 15'th Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is it Apt to Retain Haemonetics Stock in Your Portfolio Now?
08:17am, Friday, 12'th Dec 2025
HAE's Hospital rebound and rising NexSys PCS adoption boost growth prospects despite FX and solvency pressures.
– ORLADEYO now first and only targeted oral prophylactic therapy for patients with HAE aged 2 and older – -Oral pellet formulation provides child-friendly method of administration- –Showed early
Pharvaris Stock Gains on HAE Drug Meeting Late-Stage Study Goals
02:11pm, Thursday, 04'th Dec 2025
PHVS shares jump as deucrictibant delivers rapid symptom relief in RAPIDe-3, boosting momentum toward a planned 2026 regulatory filing.
Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term
10:46am, Wednesday, 03'rd Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Primary endpoint met; median time to onset of symptom relief achieved in 1.28 hours, significantly faster versus placebo (p
Fisher Asset Management LLC Cuts Position in Haemonetics Corporation $HAE
04:34am, Wednesday, 03'rd Dec 2025
Fisher Asset Management LLC lessened its position in Haemonetics Corporation (NYSE: HAE) by 6.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securit
Top 2 Health Care Stocks You May Want To Dump This Month
09:01am, Tuesday, 02'nd Dec 2025
As of Dec. 2, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Boston Partners Buys 11,738 Shares of Haemonetics Corporation $HAE
04:04am, Friday, 28'th Nov 2025
Boston Partners lifted its stake in shares of Haemonetics Corporation (NYSE: HAE) by 2.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange
Touchstone Small Company Fund Q3 2025 Performance Review
09:30am, Thursday, 27'th Nov 2025
The Touchstone Small Company Fund underperformed its benchmark, the Russell 2000 Index, for the quarter ended September 30, 2025. Among the Fund's top-performing sectors in terms of adding value were
